J
Jenny S. Sauk
Researcher at University of California, Los Angeles
Publications - 20
Citations - 1648
Jenny S. Sauk is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Inflammatory bowel disease & Crohn's disease. The author has an hindex of 6, co-authored 20 publications receiving 788 citations. Previous affiliations of Jenny S. Sauk include UCLA Medical Center.
Papers
More filters
Journal ArticleDOI
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.
Jason Lloyd-Price,Jason Lloyd-Price,Cesar Arze,Ashwin N. Ananthakrishnan,Melanie Schirmer,Melanie Schirmer,Julian Avila-Pacheco,Tiffany W. Poon,Elizabeth Andrews,Nadim J. Ajami,Kevin S. Bonham,Kevin S. Bonham,Colin J. Brislawn,David Casero,Holly Courtney,Antonio Gonzalez,Thomas G. Graeber,A. Brantley Hall,Kathleen Lake,Carol J. Landers,Himel Mallick,Himel Mallick,Damian R. Plichta,Mahadev Prasad,Gholamali Rahnavard,Gholamali Rahnavard,Jenny S. Sauk,Dmitry Shungin,Dmitry Shungin,Yoshiki Vázquez-Baeza,Richard A. White,Jonathan Braun,Lee A. Denson,Lee A. Denson,Janet K. Jansson,Rob Knight,Subra Kugathasan,Dermot P.B. McGovern,Joseph F. Petrosino,Thaddeus S. Stappenbeck,Harland S. Winter,Clary B. Clish,Eric A. Franzosa,Hera Vlamakis,Ramnik J. Xavier,Ramnik J. Xavier,Ramnik J. Xavier,Curtis Huttenhower,Curtis Huttenhower +48 more
TL;DR: It is demonstrated that periods of disease activity were also marked by increases in temporal variability, with characteristic taxonomic, functional, and biochemical shifts, and integrative analysis identified microbial, biochemical, and host factors central to this dysregulation.
Journal ArticleDOI
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Single-Center Experience.
Samantha M. Chin,Jenny S. Sauk,Jasmine Mahabamunuge,Jess L. Kaplan,Elizabeth L. Hohmann,Hamed Khalili +5 more
TL;DR: This paper presents a poster presented at the 2015 American Academy of Gastroenterology Congress, entitled “Advice and Proceedings of the Congress of the National Academy of Sciences on the Misuse of Ingredients for the Manufacture of Giants,” to discuss canine coronavirus and its role in humans.
Journal ArticleDOI
COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
Kartikeya Tripathi,Gala Godoy Brewer,Minh Thu Nguyen,Yuvaraj Singh,Mohamed Saleh Ismail,Jenny S. Sauk,Alyssa Parian,Berkeley N Limketkai +7 more
TL;DR: In this paper, the authors performed a systematic review and meta-analysis to investigate the epidemiology, clinical characteristics, and outcomes in IBD patients with COVID-19 and found that the prevalence of infection was 1.01% (95% confidence interval [CI], 0.92-1.10).
Journal ArticleDOI
Popular Diet Trends for Inflammatory Bowel Diseases: Claims and Evidence.
TL;DR: The body of evidence does not currently support clear dietary recommendations in IBD, as larger, prospective studies are needed and current data evaluating their efficacies are evaluated.
Journal ArticleDOI
The IBD-associated long noncoding RNA IFNG-AS1 regulates the balance between inflammatory and anti-inflammatory cytokine production after T-cell stimulation.
Carl R. Rankin,Ling Shao,Julie Elliott,Lorraine Rowe,Ami Patel,Elizabeth J. Videlock,Elizabeth J. Videlock,Jihane N. Benhammou,Jihane N. Benhammou,Jenny S. Sauk,Nimah Ather,Melissa Corson,Omeed Alipour,Alakh Gulati,Charalabos Pothoulakis,David Padua,David Padua +16 more
TL;DR: Non-coding RNA transcripts as potential mediators of IBD pathophysiology are focused on and a large increase in many inflammatory cytokines and a decrease in anti-inflammatory cytokines are identified after IFNG-AS1 over-expression.